UK markets closed
  • FTSE 100

    7,208.81
    +188.36 (+2.68%)
     
  • FTSE 250

    19,123.71
    +430.73 (+2.30%)
     
  • AIM

    896.27
    +10.41 (+1.18%)
     
  • GBP/EUR

    1.1618
    -0.0028 (-0.24%)
     
  • GBP/USD

    1.2270
    +0.0009 (+0.07%)
     
  • BTC-GBP

    17,515.85
    +96.00 (+0.55%)
     
  • CMC Crypto 200

    462.12
    +8.22 (+1.81%)
     
  • S&P 500

    3,911.74
    +116.01 (+3.06%)
     
  • DOW

    31,500.68
    +823.32 (+2.68%)
     
  • CRUDE OIL

    107.06
    +2.79 (+2.68%)
     
  • GOLD FUTURES

    1,828.10
    -1.70 (-0.09%)
     
  • NIKKEI 225

    26,491.97
    +320.72 (+1.23%)
     
  • HANG SENG

    21,719.06
    +445.19 (+2.09%)
     
  • DAX

    13,118.13
    +205.54 (+1.59%)
     
  • CAC 40

    6,073.35
    +190.02 (+3.23%)
     

Bavarian Nordic sells monkeypox vaccines to Canada

  • Oops!
    Something went wrong.
    Please try again later.
A laboratory of the vaccine company Bavarian Nordic, in Martinsried near Munich
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

COPENHAGEN (Reuters) - Danish biotechnology company Bavarian Nordic said on Tuesday it had signed a $56 million contract with Canada for its smallpox vaccine, which is also approved for use against monkeypox in the country, with deliveries starting next year.

"In parallel, Bavarian Nordic continues to secure contracts with other countries, including Denmark, but also countries outside Europe, to supply the vaccine to mitigate the current monkeypox outbreak", said the firm.

Bavarian will also host an investor call later on Tuesday at 1500 CET (1300 GMT).

(Reporting by Stine Jacobsen, editing by Terje Solsvik)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting